This topic contains a solution. Click here to go to the answer

Author Question: Explain the primary differences between the primary market and the secondary market. Is an IPO most ... (Read 96 times)

lak

  • Hero Member
  • *****
  • Posts: 546
Explain the primary differences between the primary market and the secondary market. Is an IPO most related to the primary market or the secondary market? Explain.

Question 2

Herzberg thought a state of complete satisfaction was common among employees.
 
 Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Tabitha_2016

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

The primary market is a market in which an investor purchases financial securities (via an investment bank) directly from the issuer of the securities. The secondary market is a market for existing financial securities that are traded between investors. Although a share of corporate stock is only sold one time in the primary market, the stock can be sold again and again in the secondary market. An initial public offering (IPO) occurs when a corporation sells common stock to the general public the first time and, therefore, is most associated with the primary market.

Answer to Question 2

False





 

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

Green tea is able to stop the scent of garlic or onion from causing bad breath.

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library